Iwona Stępniak

Safety and efficacy of pridopidine in patients with Huntington's disease (PRIDE-HD): a phase 2, randomised, placebo-controlled, multicentre, dose-ranging study

Ralf Reilmann, Andrew McGarry, Igor D. Grachev et al. · The Lancet Neurology · 2018 · 104 citations

Neurodegenerative Diseases, Medicine, Psychotropic Medication +6

Novel neuro-audiological findings and further evidence for TWNK involvement in Perrault syndrome

Monika Ołdak, Dominika Oziębło, Agnieszka Pollak et al. · Journal of Translational Medicine · 2017 · 51 citations · Full text

Next-generation sequencing study reveals the broader variant spectrum of hereditary spastic paraplegia and related phenotypes

Ewelina Elert‐Dobkowska, Iwona Stępniak, Wioletta Krysa et al. · Neurogenetics · 2019 · 50 citations · Full text

Molecular spectrum of the SPAST, ATL1 and REEP1 gene mutations associated with the most common hereditary spastic paraplegias in a group of Polish patients

Ewelina Elert‐Dobkowska, Iwona Stępniak, Wioletta Krysa et al. · Journal of the Neurological Sciences · 2015 · 32 citations

Rare Diseases, Reep1 Gene Mutations, Polish Patients +10

Two Novel Pathogenic Variants Confirm RMND1 Causative Role in Perrault Syndrome with Renal Involvement

Dominika Oziębło, J. Pazik, Iwona Stępniak et al. · Genes · 2020 · 30 citations · Full text